Glucotrack, Inc. Files 8-K

Ticker: GCTK · Form: 8-K · Filed: Dec 3, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateDec 3, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: disclosure, filing, financials

Related Tickers: GCTK

TL;DR

Glucotrack (GCTK) filed an 8-K on Dec 3rd. Standard disclosure stuff.

AI Summary

Glucotrack, Inc. filed an 8-K on December 3, 2024, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.

Why It Matters

This filing provides updates on Glucotrack, Inc.'s regulatory disclosures and financial exhibits, which are important for investors to understand the company's current status and compliance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in this header information.

What financial statements or exhibits are included in this filing?

The filing lists 'Financial Statements and Exhibits' as an item, but the specific contents are not detailed in this section.

When was Glucotrack, Inc. formerly known as Integrity Applications, Inc.?

The company changed its name from Integrity Applications, Inc. on March 28, 2022.

What is Glucotrack, Inc.'s principal executive office address?

The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

What is the SIC code for Glucotrack, Inc.?

The Standard Industrial Classification (SIC) code for Glucotrack, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-12-03 09:15:36

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 3, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing